The United States evaluates the suspension of patents for Covid-19 vaccines

The United States evaluates the suspension of patents for Covid-19 vaccines

The decision is due to the success of its vaccination campaign and would help the less affluent countries to produce the doses in their territories. Keep reading for more information!

The decision is due to the success of its vaccination campaign and would help the less affluent countries to produce the doses in their territories. Keep reading for more information!

The United States is going through the best phase of the Covid-19 pandemic so far: the success of the vaccination campaign allowed more than half of the country's adult population to have already received the vaccine and the CDC to allow transit outdoors without a mask on fully immunized people.

The United States is going through the best phase of the Covid-19 pandemic so far

Around the world, however, the situation is quite different, so the pressure for the country to temporarily suspend patents on vaccines so that they can be produced by less affluent countries grows more and more.

The White House announced that they would study this possibility as part of the search for a solution to maximize the production and global supply of vaccines at the lowest cost.

The pressure for the country to temporarily suspend patents on vaccines grows more and more.

"There are many different ways to do that. Right now, that's one of the ways, but we have to evaluate what makes the most sense," were the words of Jen Psaki, the spokeswoman for the US Government, referring to the suspension of patents. 

These statements came after the President of the United States, Joe Biden, met with the Prime Minister of India, Narendra Modi, to discuss the intellectual property of vaccines and discuss the difficult time the country is going through Asian product of the worst wave they have ever experienced.

Related Articles

More News

More News